Kovitz Investment Group Partners’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.86M Buy
82,733
+11,570
+16% +$960K 0.03% 381
2025
Q1
$5.77M Buy
71,163
+14,084
+25% +$1.14M 0.03% 381
2024
Q4
$5.14M Buy
57,079
+201
+0.4% +$18.1K 0.03% 391
2024
Q3
$5.56M Buy
56,878
+218
+0.4% +$21.3K 0.04% 326
2024
Q2
$5.25M Buy
56,660
+3,954
+8% +$367K 0.04% 278
2024
Q1
$5M Buy
52,706
+852
+2% +$80.8K 0.06% 202
2023
Q4
$4.63M Sell
51,854
-17,153
-25% -$1.53M 0.08% 162
2023
Q3
$5.04M Buy
69,007
+5,856
+9% +$428K 0.09% 135
2023
Q2
$5.25M Sell
63,151
-4,335
-6% -$361K 0.08% 137
2023
Q1
$5.14M Sell
67,486
-10,775
-14% -$821K 0.09% 146
2022
Q4
$6.5M Buy
78,261
+14,179
+22% +$1.18M 0.13% 111
2022
Q3
$5.08M Buy
64,082
+3,399
+6% +$270K 0.12% 139
2022
Q2
$4.51M Buy
60,683
+1,388
+2% +$103K 0.1% 160
2022
Q1
$5.33M Buy
59,295
+28,195
+91% +$2.53M 0.1% 151
2021
Q4
$4.38M Buy
31,100
+2,454
+9% +$345K 0.1% 139
2021
Q3
$3.6M Sell
28,646
-2,030
-7% -$255K 0.07% 182
2021
Q2
$4.15M Buy
30,676
+3,066
+11% +$415K 0.08% 173
2021
Q1
$3.75M Sell
27,610
-3,435
-11% -$466K 0.09% 155
2020
Q4
$4.37M Sell
31,045
-2,195
-7% -$309K 0.11% 134
2020
Q3
$3.7M Sell
33,240
-2,020
-6% -$225K 0.1% 137
2020
Q2
$3.95M Sell
35,260
-9,135
-21% -$1.02M 0.12% 122
2020
Q1
$3.44M Buy
44,395
+3,855
+10% +$299K 0.12% 123
2019
Q4
$3.86M Sell
40,540
-20
-0% -$1.9K 0.11% 129
2019
Q3
$3.09M Buy
40,560
+85
+0.2% +$6.48K 0.1% 151
2019
Q2
$3.55M Sell
40,475
-385
-0.9% -$33.8K 0.11% 139
2019
Q1
$3.7M Buy
+40,860
New +$3.7M 0.12% 131
2017
Q4
Sell
-3,000
Closed -$260K 163
2017
Q3
$260K Sell
3,000
-700
-19% -$60.7K 0.01% 140
2017
Q2
$286K Sell
3,700
-3,400
-48% -$263K 0.02% 134
2017
Q1
$492K Buy
+7,100
New +$492K 0.03% 97